Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the effects of sitagliptin on the need for insulin (the
hormone that lowers blood sugars) by patients who receive a pancreatectomy and islet
autotransplant for chronic pancreatitis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute